From Delmarva Now

By Brian Witte, Associated Press

July 1, 2019


In a separate new Maryland law, the state will be able to create a review board on prescription drug costs.

The five board members haven’t been named yet. Supporters say the law is a step toward creating an independent board with the authority to evaluate expensive drugs and recommend methods for addressing high costs.

Last modified: July 1, 2019